CRISIL upgrades ratings of Bafna Pharmaceuticals’ bank facilities

19 Nov 2014 Evaluate

Credit rating agency, CRISIL has upgraded rating of Bafna Pharmaceuticals’ long term bank facilities to ‘BB-’ from ‘D’. The rating agency has also upgraded rating of the company’s short term bank facilities to ‘A4+’ from ‘D’.

Bafna Pharmaceutical is a Chennai-based Pharma company engaged in the manufacturing of pharmaceutical formulations of Betalactum and Non-Betalactum. The company has 173 products registered in UK, Sri Lanka, Nepal, Ukraine, Ghana, Ethiopia, Philippines, Kryghistan, Georgia, Honduras, Colombia, Uzbekhistan, Vietnam and Nigeria.

Bafna Pharma Share Price

74.90 0.00 (0.00%)
17-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1751.05
Dr. Reddys Lab 1163.70
Cipla 1515.45
Lupin 1936.75
Zydus Lifesciences 831.40
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...